-
Review
February 28, 2024
- Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
- Jiaorong Qu, Le Wang, Yufei Li, et al.
- Clin Mol Hepatol. 2024;30(3):303-325.
Articles in E-pub version are posted online ahead of regular printed publication.
- Reply to correspondence
- Response to: Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era
- Seren M. Gedallovich, Paul Y. Kwo
- Received July 10, 2024 Accepted July 11, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0546 [Accepted]
-
View: 82 Download: 3
- Review Article
- Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
- Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao
- Received April 28, 2024 Accepted July 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0315 [Accepted]
-
View: 209 Download: 24
- Original Article
- Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
- Chuan Liu, Hong You, Qing-Lei Zeng, Yu Jun Wong, Bingqiong Wang, Ivica Grgurevic, Chenghai Liu, Hyung Joon Yim, Wei Gou, Bingtian Dong, Shenghong Ju, Yanan Guo, Qian Yu, Masashi Hirooka, Hirayuki Enomoto, Amr Shaaban Hanafy, Zhujun Cao, Xiemin Dong, Jing LV, Tae Hyung Kim, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Chuanjun Xu, Erhei Dai, Xiaoling Lan, Changxiang Lai, Shirong Liu, Fang Wang, Ying Guo, Jiaojian Lv, Liting Zhang, Yuqing Wang, Qing Xie, Chuxiao Shao, Zhensheng Liu, Liu Ravaioli, Antonio Colecchia, Jie Li, Gao-Jun Teng, Xiaolong Qi
- Received March 22, 2024 Accepted July 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0198 [Accepted]
-
View: 243 Download: 30
- Correspondence
- Correspondence on Editorial regarding “Class II Transactivator Restricts Viral Replication and Extends Its Effect to HBV”
- Mehrangiz Dezhbord, Kyun-Hwan Kim
- Received July 3, 2024 Accepted July 8, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0515 [Accepted]
-
View: 118 Download: 23
- Editorial
- Nucleos(t)ide Analog Therapy of Chronic Hepatitis B and Extrahepatic Cancer Risk: Is tenofovir better than entecavir?
- Yewan Park, Dong Hyun Sinn
- Received July 4, 2024 Accepted July 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0519 [Accepted]
-
View: 134 Download: 21
- Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind
- Beom Kyung Kim
- Received June 30, 2024 Accepted July 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0499 [Accepted]
-
View: 115 Download: 3
- Correspondence
- The role of SPP1 in MASLD pathogenesis: Therapeutic insights into ursolic acid's mechanisms of action
- Yiyuan Zheng, Zhekun Xiong, Lina Zhao, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Fengbin Liu, Yong Li
- Received June 24, 2024 Accepted July 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0471 [Accepted]
-
View: 111 Download: 12
- Correspondence on Editorial regarding“Macrophage ATG16L1: potential candidate for MASH treatment”
- Qi Wang, Qingfa Bu, Haoming Zhou, Ling Lu
- Received June 24, 2024 Accepted July 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0470 [Accepted]
-
View: 140 Download: 13
- Letter to the Editor
- Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
- Yixuan Zhu, Yee Hui Yeo, Xiaoyan Ma, Wenjing Ni, Junping Shi, Jie Li
- Received June 3, 2024 Accepted July 3, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0417 [Accepted]
-
View: 186 Download: 19
- Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy
- Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip
- Received April 18, 2024 Accepted July 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0280 [Accepted]
-
View: 147 Download: 15
- Editorial
- Class II Transactivator Restricts Viral Replication, Extending its Effect to HBV
- Cho-Rong Lee, Sung-Gyoo Park
- Received June 20, 2024 Accepted July 3, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0465 [Accepted]
-
View: 173 Download: 31
- Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis
- Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang
- Received June 25, 2024 Accepted June 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0482 [Accepted]
-
View: 250 Download: 15
- Correspondence
- Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era
- Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
- Received June 24, 2024 Accepted June 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0472 [Accepted]
-
View: 148 Download: 6
- Special Topic
- A new Korean nomenclature for steatotic liver disease: Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
- Received June 26, 2024 Accepted June 30, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0467 [Epub ahead of print]
-
View: 159 Download: 25
- Review
- Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
- Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
- Received April 3, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0222 [Accepted]
-
View: 227 Download: 42
- Editorial
- Engineering HBV-specific T cells for treatment of HBV-related HCC and HBV infection: past, present and future
- Antonio Bertoletti, Anthony T Tan
- Received June 23, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0469 [Accepted]
-
View: 181 Download: 22
- Review
- Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
- Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
- Received April 10, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0246 [Accepted]
-
View: 361 Download: 69
- Original Article
- UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL
- Renyu Zhang, Can Li, Shuai Zhang, Lingmin Kong, Zekun Liu, Yixiao Guo, Ying Sun, Cong Zhang, Yule Yong, Jianjun Lv, Meng Lu, Man Liu, Dong Wu, Tianjiao Zhang, Haijiao Yang, Ding Wei, Zhinan Chen, Huijie Bian
- Received April 7, 2024 Accepted June 24, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0236 [Accepted]
-
View: 325 Download: 72
- Burden of Mortality from Hepatocellular Carcinoma and Biliary Tract Cancers by Race and Ethnicity and Sex in US, 2018-2023
- Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
- Received April 29, 2024 Accepted June 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0318 [Accepted]
-
View: 291 Download: 17
- Correspondence
- Correspondence on Editorial regarding “Dynamic Assessment of Modified Quick Sequential Organ Failure Assessment in Acutely Deteriorated Patients with Chronic Liver Disease”
- Do Seon Song, Dong Joon Kim
- Received June 12, 2024 Accepted June 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0448 [Accepted]
-
View: 420 Download: 5
- Editorial
- Macrophage ATG16L1: potential candidate for MASH treatment
- Junjie Yu
- Received June 11, 2024 Accepted June 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0443 [Accepted]
-
View: 319 Download: 24
- Letter to the Editor
- MAFLD-related hepatocellular carcinoma in China: An increasing problem
- Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li
- Received May 22, 2024 Accepted June 17, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0386 [Accepted]
-
View: 388 Download: 26
- Editorial
- The impact of ischemia-free liver transplantation to improve the prognosis of recipients using functionally marginal liver grafts
- Ho Joong Choi
- Received June 4, 2024 Accepted June 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0426 [Accepted]
-
View: 206 Download: 15
- Metformin and Statins and their role in reducing Hepatocellular Carcinoma Risk: Randomized trials are needed
- Paul Y. Kwo
- Received June 4, 2024 Accepted June 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0425 [Accepted]
-
View: 264 Download: 22
- Meeting the challenges of HCC post SVR in the Post-DAA Era: A Path Forward
- Seren M. Gedallovich, Paul Y. Kwo
- Received June 3, 2024 Accepted June 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0418 [Accepted]
-
View: 195 Download: 10
- Ursolic acid: A promising therapeutic agent for MASLD via inhibition of SPP1-induced Th17 cell differentiation
- So Jung Kim, Jeongeun Hyun
- Received May 31, 2024 Accepted June 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0412 [Accepted]
-
View: 314 Download: 29
- Modified quick-SOFA score: can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?
- Simone Incicco, Salvatore Piano
- Received May 30, 2024 Accepted May 31, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0409 [Accepted]
-
View: 192 Download: 7
- Correspondence
- Correspondence on editorial regarding “Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?”
- Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
- Received May 24, 2024 Accepted May 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0394 [Accepted]
-
View: 368 Download: 24
- Original Article
- Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC
- Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du
- Received January 20, 2024 Accepted May 28, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0058 [Accepted]
-
View: 502 Download: 77
- Editorial
- MAFLD Is A Ubiquitous Latent Cofactor in Viral- and Alcoholic-related Hepatocellular Carcinoma
- Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, Keisuke Amano, Takumi Kawaguchi
- Received May 18, 2024 Accepted May 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0372 [Accepted]
-
View: 422 Download: 27
- Correspondence
- Correspondence on Editorial regarding “Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: a gateway to personalized medicine”
- Su Bin Lim, Hyo Jung Cho
- Received May 16, 2024 Accepted May 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0368 [Accepted]
-
View: 358 Download: 20
- Reply to Unlocking the future: machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- Received May 16, 2024 Accepted May 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0365 [Accepted]
-
View: 330 Download: 10
- Reply to Correspondence
- Reply to correspondence: “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
- Eileen Laurel Yoon, Dae Won Jun
- Received May 15, 2024 Accepted May 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0360 [Accepted]
-
View: 340 Download: 9
- Letter to the Editor
- Equivalent Prevalence and Progression of Chronic Kidney Disease in NAFLD and MASLD
- Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
- Received April 15, 2024 Accepted May 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0264 [Accepted]
-
View: 431 Download: 50
- Correspondence
- Correspondence on Letter regarding “Liver Sinusoidal Endothelial Cell: An Important Yet Often Overlooked Player in the Liver Fibrosis”
- Jiaorong Qu, Le Wang, Xiaojiaoyang Li
- Received May 14, 2024 Accepted May 15, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0357 [Accepted]
-
View: 338 Download: 23
- Editorial
- Unveiling Etiology-Specific Blood Biomarkers in Hepatocellular Carcinoma: A Gateway to Personalized Medicine
- Joseph C. Ahn, Ju Dong Yang
- Received May 10, 2024 Accepted May 13, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0348 [Accepted]
-
View: 369 Download: 6
- Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure
- Hae Lim Lee, Jeong Won Jang
- Received May 9, 2024 Accepted May 13, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0346 [Accepted]
-
View: 247 Download: 21
- Unlocking the Role of Liver Sinusoidal Endothelial Cells: Key Players in Liver Fibrosis
- Yasuko Iwakiri
- Received May 8, 2024 Accepted May 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0343 [Accepted]
-
View: 370 Download: 44
- Letter to the Editor
- Changing from NAFLD to MASLD: Cumulative incidence of gallstones between patients with NAFLD and those with MASLD in Asia
- Shuhei Fukunaga, Tomoyuki Nakane, Michita Mukasa, Hidetoshi Takedatsu, Takumi Kawaguchi
- Received April 7, 2024 Accepted May 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0233 [Accepted]
-
View: 381 Download: 30 Crossref: 1
- Editorial
- Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
- Junlong Dai, Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
- Received May 3, 2024 Accepted May 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0327 [Epub ahead of print]
-
View: 342 Download: 18
- Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?
- Naoshi Nishida
- Received May 2, 2024 Accepted May 3, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0324 [Accepted]
-
View: 328 Download: 41
- Reply to Correspondence
- Complement proteins and liver diseases: A response to the correspondence
- Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
- Received April 30, 2024 Accepted April 30, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0320 [Epub ahead of print]
-
View: 477 Download: 36
- Correspondence
- Reply to: “Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization”
- Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu
- Received April 16, 2024 Accepted April 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0266 [Epub ahead of print]
-
View: 426 Download: 16
- Reply to correspondence
- Reply to correspondence regarding “Evaluation of the histological scoring systems for autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis”
- Atsumasa Komori
- Received April 9, 2024 Accepted April 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0242 [Epub ahead of print]
-
View: 591 Download: 16
- Reply to Correspondence
- Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B”
- Pin-Nan Cheng, Ming-Lung Yu
- Received April 5, 2024 Accepted April 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0228 [Epub ahead of print]
-
View: 535 Download: 24
- Snapshot
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Anna Brujats, Càndid Villanueva
- Received February 24, 2024 Accepted March 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0144 [Epub ahead of print]
-
View: 1133 Download: 33
